SUMATRIPTAN SUCCINATE INJECTABLE
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D217R0032
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
This presolicitation notice pertains to the procurement of Sumatriptan Succinate Injectable, a pharmaceutical product used primarily for the treatment of migraine headaches. The activity is managed by DLA Troop Support, a federal office responsible for providing medical supplies to military and other government entities. The procurement falls under NAICS Code 325412, which covers Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating drugs and biologicals.
The scope of this procurement centers on the supply of Sumatriptan Succinate in injectable form, specifically the 6MG/0.5ML vial configuration, packaged as five vials per pack. The notice references several contract modifications (P00003 through P00007) to the existing contract SPE2D2-18-D-0053, including the invocation of contract options and a price adjustment for the specified product. Additionally, modification P00004 incorporates Federal Acquisition Regulation (FAR) clauses 52.204-24 and 52.204-25, which address security and supply chain requirements, ensuring compliance with federal standards for information and communications technology.
The intended outcome of this procurement is to maintain a reliable supply of Sumatriptan Succinate Injectable for government use, with contract options invoked to extend or modify the terms as needed. Contractors are expected to deliver the specified pharmaceutical product in accordance with the contract requirements, including packaging, labeling, and regulatory compliance.
DLA Troop Support serves as the contracting entity, with Phyllis Daraio as the primary point of contact for inquiries related to this opportunity. She can be reached at [email protected] or by phone at 215-737-7941. The notice was originally posted on May 23, 2022, but is currently inactive, with a response date listed as November 3, 2017.
This opportunity is relevant for manufacturers and suppliers with capabilities in pharmaceutical preparation, particularly those experienced in producing and packaging injectable medications for government contracts. Key considerations include adherence to federal acquisition regulations, responsiveness to contract modifications, and the ability to meet ongoing supply requirements over the contract lifecycle. Interested parties should review the full solicitation and associated attachments for detailed specifications and compliance requirements.
For further information and access to related documents, contractors may refer to the official notice on SAM.gov using Opportunity ID 889fd6fa73d14bfb890202a4c274ee8b.
Documents10